The Inland Northwest’s Leader in Movement Disorder Research

Bringing experimental therapeutics to Spokane, with over 50 successful clinical trials completed since 2017.

Contact Us

Diseases We Study

  • Parkinson's Disease

  • Huntington's Disease

  • Essential Tremor

  • Multiple System Atrophy (MSA)

  • Dystonia

  • Ataxia

Our Trials

  • Actively recruiting participants with movement disorders to participate in clinical trials.

  • Conducting clinical studies to advance research in Parkinson’s disease, Huntington’s disease, Essential Tremor, MSA, Ataxia, and other movement and movement disorders.

  • Collaborating with national and global initiatives to focus on unmet clinical needs of patients living with movement disorders

Find a Clinical Trial
 

Our clinic is conveniently located just off I-90 in Spokane, Washington.

Featured Trials

Annovis - ANVS-25002 PD OLE

This study will examine the long-term safety of buntanetap in participants with PD. This will be a 36-month open-label safety study. This study will be conducted with two cohorts. Cohort 1 will enroll via invitation only for PD participants who have previously participated in buntanetap clinical trials. Cohort 2 will be for PD participants who are receiving deep brain stimulation (DBS) treatment. Qualified participants will receive buntanetap 30mg QD after a screening period of up to 42 days.

Learn more

Vima - VIM0423-201 Stride

Stride Dystonia is a randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of VIM0423 in individuals with isolated dystonia.

The main objectives of this clinical trial are to determine the following: Does VIM0423 therapy improve dystonia symptoms compared to placebo? Is VIM0423 well tolerated in individuals with isolated dystonia? anf do the therapeutic effects of VIM0423 confer improvements on daily function and quality of life?

Learn more

Our Leadership

  • Jason Aldred, M.D., FAAN

    Dr. Jason Aldred, MD, FAAN, is a board-certified neurologist with specialized fellowship training in Parkinson's disease & movement disorders. He serves as the Principal Investigator for all clinical trials at our site. Dr. Aldred is a credentialed investigator with major research groups, ensuring the proper and ethical conduct of our studies.

  • Michael Dauer, MS, MBA

    Mike brings over 16 years of experience leading research and diagnostic teams at institutions like the University of Washington and Adaptive Biotechnologies. He oversees INWR’s daily operations and long-term strategy, ensuring high-quality trial execution, team support, and excellent sponsor collaboration.

Our Team

“Participating in an INWR trial gave me hope and helped contribute to finding a cure for people with Parkinson’s disease.”

— Parkinson’s Participant